Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: Zongtao Tom Lin
Year: 2024
Reference:
1. Lin*, Xie, Gongora, Liu, Zahn, Palai, Ramirez, Searfoss, Vitorino, Dann, Zhao, Han, MacTaggart, Lan, Fu, Greenberg, Zhang, Lavine, Greenberg, Lv, Kashina, Garcia*. An Unbiased Proteomic Platform for Activity-based Arginylation Profiling. 2024. bioRxiv. Nature Chem. Bio. (under review). PMID: 38854050
2. Xie*, Brás-Costa, Lin, Garcia*.Mass spectrometry analysis of nucleic acid modifications: from beginning to future. Mass Spectrometry Reviews. 2024. (under review).
Name: Suzanne Schindler
Year: 2024
Reference:
Buckley RF, Schindler SE. Lower Accuracy Alzheimer Disease Blood Tests Will Never Be “Ready for Prime Time”. Neurology. 2024 Apr 23;102(8):e209295. doi: 10.1212/WNL.0000000000209295. Epub 2024 Mar 25. PMID: 38527244.
Name: Suzanne Schindler
Year: 2024
Reference:
Delvenne A, Gobom J, Schindler SE, Kate MT, Reus LM, Dobricic V, Tijms BM, Benzinger TLS, Cruchaga C, Teunissen CE, Ramakers I, Martinez-Lage P, Tainta M, Vandenberghe R, Schaeverbeke J, Engelborghs S, Roeck E, Popp J, Peyratout G, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Barkhof F, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vos SJB. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer’s disease. Alzheimers Dement. 2024 Jul 6. PMID: 38970402.
Name: Susan Stark
Year: 2024
Reference:
Keleman, A.A., Bollinger, R.M., Rodakowski, J., Chang, C-H., Kehrer-Dunlap A., Ances, B.M., & Stark, S.L. (in press). Exploring the Remote Administration of a Performance-Based Functional Assessment. Journal of Applied Gerontology.
Name: Nicole McKay
Year: 2024
Reference:
McKay NS, Millar PR, Nicosia J, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Cruchaga CC, Schindler SE, Morris JC, Hassenstab J. Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research. Neuropsychology. 2024 Jul;38(5):443-464. doi: 10.1037/neu0000949. Epub 2024 Apr 11. PubMed PMID: 38602816; PubMed Central PMCID: PMC11176005.
Name: Peter Millar
Year: 2024
Reference:
McKay, NS, Millar, PR, Aschenbrenner, AJ, Robinson, C, Pedersen, TJ, Hobbs, DA, Hassenstab, JJ, Morris, JC, Benzinger, TLS, Huff, MJ, Balota, DA, & Gordon, BA (submitted). White matter microstructure associates with global but not local task-switching costs.
Name: Millar Peter
Year: 2024
Reference:
McKay, NS, Millar, PR, Nicosia, J, Aschenbrenner, AJ, Gordon, BA, Benzinger, TLS, Cruchaga, CC, Schindler, SE, Morris, JC, & Hassenstab, JJ (2024). Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research. Neuropsychology. DOI: 10.1037/neu0000949 PMID: 38602816.
Name: Peter Millar
Year: 2024
Reference:
McKay, NS, Millar, PR, Nicosia, J, Aschenbrenner, AJ, Gordon, BA, Benzinger, TLS, Cruchaga, CC, Schindler, SE, Morris, JC, & Hassenstab, JJ (2024). Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research. Neuropsychology. DOI: 10.1037/neu0000949 PMID: 38602816.
Name: Suzanne Schindler
Year: 2024
Reference:
Meeker KL, Luckett PH, Barthélemy NR, Hobbs DA, Chen C, Bollinger J, Ovod V, Flores S, Keefe S, Henson RL, Herries EM, McDade E, Hassenstab JJ, Xiong C, Cruchaga C, Benzinger TLS, Holtzman DM, Schindler SE, Bateman RJ, Morris JC, Gordon BA, Ances BM. Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer’s disease. Brain Commun. 2024 Mar 15;6(2):fcae081. doi: 10.1093/braincomms/fcae081. PMID: 38505230; PMCID: PMC10950051.
Name: Suzanne Schindler
Year: 2024
Reference:
Pereira AC, Schindler SE. Cerebrospinal fluid testing in dementia diagnosis. Practical Neurology (US). 2024;23(5):23-24.
Name: Suzanne Schindler
Year: 2024
Reference:
Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Suárez-Calvet M, Khachaturian AS, Mielke MM, Udeh-Momoh C, Weiss J, Batrla R, Bozeat S, Dwyer JR, Holzapfel D, Jones DR, Murray JF, Partrick KA, Scholler E, Vradenburg G, Young D, Algeciras-Schimnich A, Aubrecht J, Braunstein JB, Hendrix J, Hu YH, Mattke S, Monane M, Reilly D, Somers E, Teunissen CE, Shobin E, Vanderstichele H, Weiner MW, Wilson D, Hansson O. Acceptable performance of blood biomarker tests of amyloid pathology – recommendations from the Global CEO Initiative on Alzheimer’s Disease. Nat Rev Neurol. 2024 Jul;20(7):426-439. doi: 10.1038/s41582-024-00977-5. Epub 2024 Jun 12. PMID: 38866966.
Name: Suzanne Schindler
Year: 2024
Reference:
Sexton CE, Bitan G, Bowles KR, Brys M, Buée L, Maina MB, Clelland CD, Cohen AD, Crary JF, Dage JL, Diaz K, Frost B, Gan L, Goate AM, Golbe LI, Hansson O, Karch CM, Kolb HC, La Joie R, Lee SE, Matallana D, Miller BL, Onyike CU, Quiroz YT, Rexach JE, Rohrer JD, Rommel A, Sadri-Vakili G, Schindler SE, Schneider JA, Sperling RA, Teunissen CE, Weninger SC, Worley SL, Zheng H, Carrillo MC. Novel avenues of tau research. Alzheimers Dement. 2024 Jan 3. doi: 10.1002/alz.13533. Epub ahead of print. PMID: 38170841.
Name: Millar Peter
Year: 2024
Reference:
Stojanovic, M, Millar, PR, McKay, NS, Aschenbrenner, AJ, Balota, DA, Hassenstab, JJ, Benzinger, TLS, Morris, JC, & Ances, BM (under revision). The associations between attentional control, episodic memory, and Alzheimer disease biomarkers of tau and neurodegeneration.
Name: Peter Millar
Year: 2024
Reference:
Stojanovic, M, Millar, PR, McKay, NS, Aschenbrenner, AJ, Balota, DA, Hassenstab, JJ, Benzinger, TLS, Morris, JC, & Ances, BM (under revision). The associations between attentional control, episodic memory, and Alzheimer disease biomarkers of tau and neurodegeneration.
Name: Suzanne Schindler
Year: 2024
Reference:
Therriault J, Schindler SE, Salvadó G, Pascoal TA, Benedet AL, Ashton NJ, Karikari TK, Apostolova L, Murray ME, Verberk I, Vogel JW, La Joie R, Gauthier S, Teunissen C, Rabinovici GD, Zetterberg H, Bateman RJ, Scheltens P, Blennow K, Sperling R, Hansson O, Jack CR Jr, Rosa-Neto P. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1. PMID: 38429551.
Name: Millar Peter
Year: 2024
Reference:
Tu, JC, Millar, PR, Strain, JF, Eck, A, Adeyemo, B, Snyder, AZ, Daniels, A, Karch, C, Huey, ED, McDade, E, Day, GS, Yakushev, I, Hassenstab, JJ, Morris, JC, Llibre-Guerra, JJ, …, Ances, BM, Eggebrecht, AT, Gordon, BA, & Wheelock, MD (in press). Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease. Network Neuroscience. DOI: 10.1162/netn_a_00395.
Name: Peter Millar
Year: 2024
Reference:
Tu, JC, Millar, PR, Strain, JF, Eck, A, Adeyemo, B, Snyder, AZ, Daniels, A, Karch, C, Huey, ED, McDade, E, Day, GS, Yakushev, I, Hassenstab, JJ, Morris, JC, Llibre-Guerra, JJ, …, Ances, BM, Eggebrecht, AT, Gordon, BA, & Wheelock, MD (in press). Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease. Network Neuroscience. DOI: 10.1162/netn_a_00395.
Name: Suzanne Schindler
Year: 2023
Reference:
Barthélemy NR, Saef B, Li Y, Gordon BA, He Y, Horie K, Stomrud E, Salvadó G, Janelidze S, Sato C, Ovod V, Henson RL, Fagan AM, Benzinger TLS, Xiong C, Morris JC, Hansson O, Bateman RJ, Schindler SE. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease. Nature Aging. 2023. 1-11.
Name: Suzanne Schindler
Year: 2023
Reference:
Bayat S, Roe CM, Schindler S, Murphy SA, Doherty JM, Johnson AM, Walker A, Ances BM, Morris JC, Babulal GM. Everyday Driving and Plasma Biomarkers in Alzheimer’s Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit. J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268. Epub ahead of print. PMID: 36938737.
Name: Susan Stark
Year: 2023
Reference:
Bollinger RM, Gabel M, Coble DW, Chen SW, Keleman A, Doralus J, Chin E, Lingler JH, Grill JD, Stark SL, Edwards DF. Retention of study partners in longitudinal studies of Alzheimer disease. Submitted to Journal of Alzheimer’s Disease
Name: Rebecca Bollinger
Year: 2023
Reference:
Bollinger RM, Gabel M, Coble DW, et al. Retention of Study Partners in Longitudinal Studies of Alzheimer Disease. Journal of Alzheimer’s Disease 2023; 94(1):189-199. DOI: 10.3233/jad-230079. PMID: 37212114.
Name: Suzanne Schindler
Year: 2023
Reference:
Bonomi S, Gupta MR, Schindler SE. Inadequate reimbursement for lumbar puncture is a potential barrier to accessing new Alzheimer’s disease treatments. Alzheimers Dement. 2023 Sep 18. doi: 10.1002/alz.13473. Epub ahead of print. PMID: 37718645.
Name: Suzanne Schindler
Year: 2023
Reference:
Bradley J, Gorijala P, Schindler SE, Sung YJ, Ances B, Neuroimaging Initiative The Human Connectome Project TAD, Fernandez MV, Cruchaga C. Genetic architecture of plasma Alzheimer disease biomarkers. Hum Mol Genet. 2023 May 19:ddad087. doi: 10.1093/hmg/ddad087. Epub ahead of print. PMID: 37208024.
Name: Suzanne Schindler
Year: 2023
Reference:
Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, Lopez S, Ovod V, Nakamura A, Shaw LM, Zetterberg H, Hansson O, Bateman RJ. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review. Alzheimers Res Ther. 2022 Dec 27;14(1):195. doi: 10.1186/s13195-022-01117-1. PMID: 36575454; PMCID: PMC9793600.
Name: David Carr
Year: 2023
Reference:
Carr DB and Babulal GM. Addressing the Complex Driving Needs of an Aging Population. JAMA. 2023;330(12):1187-1188. doi:10.1001/jama.2023.16093. MIHMSID 1935927